DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nestorov, I.
Right arrow Articles by Rowland, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nestorov, I.
Right arrow Articles by Rowland, M.

Vol. 30, Issue 3, 276-282, March 2002

Incorporating Measures of Variability and Uncertainty into the Prediction of in Vivo Hepatic Clearance from in Vitro Data

Ivan Nestorov, Ivelina Gueorguieva, Hannah M. Jones, Brian Houston, and Malcolm Rowland

Centre for Applied Pharmacokinetic Research (I.N., I.G., H.M.J., B.H., M.R.) and School of Pharmacy and Pharmaceutical Sciences (B.H., M.R.), University of Manchester, Manchester, United Kingdom

The existing procedures for quantitative in vitro-in vivo clearance prediction can be significantly biased either by totally neglecting the existing variability and uncertainty by using mean parameter values or by implementing Monte Carlo simulation with statistical distribution of the parameters reconstructed from very small sets of data. The aim of the present study is to develop a methodology for the prediction of in vivo hepatic clearance in the presence of semiquantitative or qualitative data and accounting for the existing uncertainty and variability. The method consists of two steps: 1) transformation of the information available into fuzzy sets (fuzzification); and 2) computation of the in vivo clearance using arithmetic operations with fuzzy sets. To illustrate the approach, rat hepatocyte and microsomal data for eight benzodiazepine compounds are used. A comparison with a standard Monte Carlo procedure is made. The methodology proposed can be used when Monte Carlo simulation may be biased or cannot be implemented. The obtained fuzzy in vivo clearance can be used subsequently in fuzzy simulations of pharmacokinetic models.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
R. S. Obach, F. Lombardo, and N. J. Waters
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds
Drug Metab. Dispos., July 1, 2008; 36(7): 1385 - 1405.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. A. Totah, K. E. Allen, P. Sheffels, D. Whittington, and E. D. Kharasch
Enantiomeric Metabolic Interactions and Stereoselective Human Methadone Metabolism
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 389 - 399.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. Y. Chien, A. Lucksiri, C. S. Ernest II, J. C. Gorski, S. A. Wrighton, and S. D. Hall
STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE
Drug Metab. Dispos., July 1, 2006; 34(7): 1208 - 1219.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Galetin, K. Ito, D. Hallifax, and J. B. Houston
CYP3A4 Substrate Selection and Substitution in the Prediction of Potential Drug-Drug Interactions
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 180 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. Ito, D. Hallifax, R. S. Obach, and J. B. Houston
IMPACT OF PARALLEL PATHWAYS OF DRUG ELIMINATION AND MULTIPLE CYTOCHROME P450 INVOLVEMENT ON DRUG-DRUG INTERACTIONS: CYP2D6 PARADIGM
Drug Metab. Dispos., June 1, 2005; 33(6): 837 - 844.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.